VEGF-B ANTIBODY AND INTERLEUKIN-22 FUSION PROTEIN AMELIORATES DIABETIC NEPHROPATHY THROUGH INHIBITING LIPID ACCUMULATION AND INFLAMMATORY RESPONSES

VEGF-B antibody and interleukin-22 fusion protein ameliorates diabetic nephropathy through inhibiting lipid accumulation and inflammatory responses

Diabetic nephropathy (DN) is considered the primary causes of end-stage renal disease (ESRD) and is related to abnormal glycolipid metabolism, hemodynamic abnormalities, oxidative stress and chronic inflammation.Antagonism of vascular endothelial growth factor B (VEGF-B) could efficiently ameliorate DN by reducing renal lipotoxicity.However, this p

read more

Fog Forecast Using WRF Model Output for Solar Energy Applications

The occurrence of fog often causes errors in the prediction of the incident solar radiation and the power produced by photovoltaic cells.An accurate fog forecast would benefit solar energy producers and L-Glutamine grid operators, who could take coordinated actions to reduce the impact of discontinuity, the main drawback of renewable energy sources

read more